ALX Oncology Holdings Inc.

ALX Oncology Holdings Inc. - ROEverified

ALXO

Price:

$1.93

Market Cap:

$259.71M

ALX Oncology Holdings Inc., a clinical-stage immuno-oncology company, focuses on developing therapies for cancer patients in the United States. The company’s lead product candidate is Evorpacept, a CD47 blocking therapeutic biologic development as a combination therapy with other anti-cancer agents, including ASPEN-06, under phase 2 clinical study for treating Gastric/GEJ cancer. It has collaboration agreement for Evorpacept combination programs comprising Jazz Pharmaceuticals plc for zanidatamab, under phase 1b/2 trial for the treatment of breast cancer and other solid tumors; HER2 with an ADC, fam-trastuzumab deruxtecan-nxki, under phase 1 trial for the treatment of patients with breast ca...[Read more]

Industry

Biotechnology

IPO Date

2020-07-17

Stock Exchange

NASDAQ

Ticker

ALXO

The ROE as of August 2026 (TTM) for ALX Oncology Holdings Inc. (ALXO) is -124.06%

According to ALX Oncology Holdings Inc.’s latest financial reports and current stock price. The company's current ROE is -124.06%. This represents a change of 161.86% compared to the average of -47.37% of the last 4 quarters.

ALX Oncology Holdings Inc. (ALXO) Historical ROE (quarterly & annually)

How has ALXO ROE performed in the past?

The mean historical ROE of ALX Oncology Holdings Inc. over the last ten years is 768.34%. The current -124.06% ROE has changed -116.15% with respect to the historical average. Over the past ten years (40 quarters), ALXO's ROE was at its highest in in the December 2019 quarter at 2.81%. The ROE was at its lowest in in the December 2025 quarter at -87.94%.

Quarterly (TTM)
Annual

Average

768.34%

Median

-65.82%

Minimum

-391.42%

Maximum

6.97%

ALX Oncology Holdings Inc. (ALXO) ROE by Quarter and Year

Discovering the peaks and valleys of ALX Oncology Holdings Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 229.79%

Maximum Annual ROE = 6.97%

Minimum Annual Increase = -4748.58%

Minimum Annual ROE = -391.42%

Quarterly (TTM)
Annual
YearROEChange
2025-391.42%229.79%
2024-118.69%40.02%
2023-84.76%80.85%
2022-46.87%103.87%
2021-22.99%116.05%
2020-10.64%-100.15%
20196.97%-4748.58%

ALX Oncology Holdings Inc. (ALXO) Average ROE

How has ALXO ROE performed in the past?

The current ROE of ALX Oncology Holdings Inc. (ALXO) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages

3-year avg

-198.29%

5-year avg

-132.95%

10-year avg

768.34%

ALX Oncology Holdings Inc. (ALXO) ROE vs. Peers

How is ALXO’s ROE compared to its peers?

ALX Oncology Holdings Inc.’s ROE is greater than Precision BioSciences, Inc. (-79.62%), greater than Repare Therapeutics Inc. (-37.24%), greater than Fractyl Health, Inc. (-4573.89%), greater than aTyr Pharma, Inc. (-99.87%), greater than Artiva Biotherapeutics, Inc. (-73.16%), less than Adverum Biotechnologies, Inc. (872.77%), greater than Biomea Fusion, Inc. (-196.72%), greater than Metagenomi, Inc. Common Stock (-51.23%), greater than Immunic, Inc. (-220.75%), less than Sutro Biopharma, Inc. (192.77%),

Build a custom stock screener for ALX Oncology Holdings Inc. (ALXO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like ALX Oncology Holdings Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

ALX Oncology Holdings Inc. (ALXO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like ALX Oncology Holdings Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is ALX Oncology Holdings Inc.'s ROE?

How is the ROE calculated for ALX Oncology Holdings Inc. (ALXO)?

What is the highest ROE for ALX Oncology Holdings Inc. (ALXO)?

What is the 3-year average ROE for ALX Oncology Holdings Inc. (ALXO)?

What is the 5-year average ROE for ALX Oncology Holdings Inc. (ALXO)?

How does the current ROE for ALX Oncology Holdings Inc. (ALXO) compare to its historical average?